News Search Results
Sep 25, 2024, 15:04 ET Illinois Academy of Family Physicians Launches 'Adults Need Vaccines Too' Campaign
their primary care physicians about doing the same." The most common viruses, including COVID-19, influenza (flu), and respiratory syncytial virus (RSV,) start to peak in the fall and winter. COVID-19 continues to circulate in Illinois and is especially dangerous
More news about: Illinois Academy of Family Physicians
Sep 25, 2024, 14:35 ET The Commercial Airport Lighting Market is projected to grow by USD 140.9 Million from 2024-2028, with AI driving transformation and rising air traffic boosting growth - Technavio
maintenance is essential to ensure the longevity of these systems. Revenues in the market are expected to decline in the short term due to the impact of the COVID-19 pandemic on air travel. However, the long-term outlook remains healthy, driven by aviation strategy and funds allocated for airport expansion projects.
More news about: Technavio
Sep 25, 2024, 10:00 ET Trackonomy Launches Label Tracking SmartTape To Transform Supply Chain Visibility
SmartTape has already demonstrated reliable on-time delivery and optimization across the entire supply chain. It played a critical role during the COVID-19 pandemic to help achieve 99.9% on-time delivery as featured during the LogiPharma keynote by UPS and Trackonomy. SmartTape is now available
More news about: Trackonomy Systems
Sep 25, 2024, 10:00 ET Extreme Networks, Inc. (EXTR) Investors: October 15, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
alleges that: (1) Extreme suffered from weak client demand trends due to customers ordering more product than necessary in the wake of the COVID-19 pandemic; (2) the company attempted to offset the negative organic demand trends with backlog orders exceeding the proportion it represented to investors;
More news about: Kessler Topaz Meltzer & Check, LLP
Sep 25, 2024, 09:42 ET Akita Biosciences Unveils Groundbreaking Peer-Reviewed Data on Innovative Nasal Spray Technology
form a gel-like barrier in the nasal passages to capture, block, and neutralize these pathogens for several hours. "We know that influenza, COVID-19, and other seasonal infections cause thousands of deaths and make hundreds of thousands seriously ill every year. In our research, we looked at how
More news about: Akita Biosciences
Sep 25, 2024, 09:00 ET As Concerns about Respiratory Diseases Among Public Drop to New Lows, US Health Officials Urge Vaccination
data, COVID-19 vaccination rates are significantly lower than flu vaccination rates—only 23% of US adults age 18 years and older got an updated COVID-19 vaccine during the 2023-2024 respiratory season versus 45% who got a flu vaccine. And while individuals can safely get both flu and COVID-19 vaccines
More news about: National Foundation for Infectious Diseases
Sep 25, 2024, 08:30 ET ZI Investors Have Opportunity to Lead Zoom Info Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm
Complaint, the Company made false and misleading statements to the market. ZoomInfo's financial results were unsustainably inflated by the effects of COVID-19. A substantial portion of the Company's customer base was attempting to reduce their use of its products. The Company used manipulative auto-renew
More news about: The Schall Law Firm
Sep 25, 2024, 08:00 ET Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the
More news about: Novavax, Inc.
Sep 25, 2024, 08:00 ET Vanderbilt University School of Medicine Basic Sciences Adds Carterra's LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care
used by pharmaceutical giant Eli Lilly during the COVID-19 pandemic to find antibodies effective against SARS-CoV-2. Within 90 days of isolating antibodies from an early COVID-19 survivor, Lilly was in clinical trials with the world's first COVID-19 therapeutic, the antibody Bamlanivimab.
More news about: Carterra
Sep 25, 2024, 08:00 ET SolarBank to Present at Premier Growth Conference This Week - Arcstone Kingswood Growth Summit 2024
environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems
More news about: SolarBank Corporation
Sep 25, 2024, 08:00 ET MIFFLINBURG BANCORP, INC. AND NORTHUMBERLAND BANCORP ANNOUNCE STRATEGIC MERGER OF EQUALS
Mifflinburg and Northumberland; uncertainty as to the extent of the duration, scope, and impacts of the COVID-19 pandemic on Mifflinburg, Northumberland and the proposed transaction; and the other
More news about: Mifflinburg Bancorp, Inc.
Sep 25, 2024, 08:00 ET MIFFLINBURG BANCORP, INC. AND NORTHUMBERLAND BANCORP ANNOUNCE STRATEGIC MERGER OF EQUALS
Mifflinburg and Northumberland; uncertainty as to the extent of the duration, scope, and impacts of the COVID-19 pandemic on Mifflinburg, Northumberland and the proposed transaction; and the other
More news about: Mifflinburg Bancorp, Inc.
Sep 25, 2024, 03:30 ET Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024
of clinical trials and the availability of clinical data may be delayed or unsuccessful due to challenges caused by health epidemics, including the COVID-19 pandemic, regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory
More news about: Nektar Therapeutics
Sep 24, 2024, 21:25 ET The vaccine research market is projected to grow by USD 21.4 Billion from 2024-2028, with AI redefining the landscape and rising infectious diseases driving revenue - Technavio
(NIH). In response to the COVID-19 pandemic, governments worldwide have made substantial investments, with the US alone spending approximately USD31.2 billion in 2020 and an additional USD31.9 billion in 2023 on COVID-19 vaccine development.
More news about: Technavio
Sep 24, 2024, 18:39 ET UNTourism 表示，加快旅遊業採取氣候行動對提升行業和旅遊目的地的韌性有著重要意義
國家旅遊部長會議上呼籲各國亟需採取措施，促進旅遊業的全面轉型，繼而惠及環境和當地社群。隨著旅遊業有望在今年年末恢復至疫情前的水平，Pololikashvili 強調除復甦外更應著眼未來，重視旅遊業可帶來積極的變化。他在發言時特別表示，應讓當地社群有更多的話語權，採取切實可行的氣候行動，以及促進注重自然與循環的可持續經濟發展。 全球旅遊持續從 COVID-19 疫情穩步恢復。數據顯示 2023 年上半年的國際旅客入境人數已達到 2019 年的 80% 水平。某些地區，尤其是中東和歐洲，甚至已超過這些數字。然而，受持續的旅行限制，亞洲和太平洋等地區的復甦步調趨緩。這一復甦趨勢強化了旅遊業在推動全球經濟增長、創造就業機會和促進倚重旅遊業地區的發展方面起到關鍵作用。
More news about: UNTOURISM GLOBAL HUB. MADRID HQ
Sep 24, 2024, 17:54 ET G7 DFIs, MedAccess, EIB, and IFC Announce MoU for Surge Financing Initiative for Medical Countermeasures
collaboration frameworks and innovative financing mechanisms needed to support a rapid and equitable pandemic response. Building on lessons from the COVID-19 pandemic, the initiative will focus on the procurement, production, and distribution of vaccines, therapeutics, diagnostics, and other MCMs for low-
More news about: U.S. International Development Finance Corporation dba Carahsoft
Sep 24, 2024, 17:27 ET Aluminum Pigment Market size is set to grow by USD 168.6 million from 2024-2028, growing demand for aluminum pigment from automotive sector boost the market- Technavio
production. The relaxation of sanctions in July 2018 resulted in a price decline, but the rate of decline slowed. In 2020, the COVID-19 pandemic caused global economic downturn and weak demand, leading to a decline in aluminum prices. In March 2022, the
More news about: Infiniti Research, Inc.
Sep 24, 2024, 16:00 ET TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE
constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials
More news about: Amgen
Sep 24, 2024, 15:50 ET MEI Investors Have Opportunity to Lead Methode Electronics, Inc. Securities Fraud Lawsuit
defendants made false and/or misleading statements and/or failed to disclose that: (1) Methode had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode's transition from its historic low mix, high volume production model to a high mix, low production
More news about: THE ROSEN LAW FIRM, P. A.
Sep 24, 2024, 15:45 ET FDA Roundup: September 24, 2024
peripheral sensory neuropathy, pneumonia, musculoskeletal pain, cataract, constipation, peripheral edema, rash, infusion-related reaction, insomnia, and COVID-19 infection. Full prescribing information for Sarclisa will be posted on Drugs@FDA. On
More news about: U.S. Food and Drug Administration
Sep 24, 2024, 15:30 ET MEI Investors Have Opportunity to Lead Methode Electronics, Inc. Securities Fraud Lawsuit
throughout the Class Period, Defendants failed to disclose to investors: (1) that the Company had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete the Company's transition from its historic low mix, high volume production model to a high mix, low production
More news about: Glancy Prongay & Murray LLP
Sep 24, 2024, 15:28 ET Global Cell Therapy Biomanufacturing Market Projected to Reach $16.7 Billion by 2029
environments, alongside market projections and competitive landscape insights. Additionally, it includes company profiles and evaluates the impact of COVID-19 on the biologic's safety testing market. Directly Purchase a
More news about: BCC Research LLC
Sep 24, 2024, 14:35 ET The instant noodles market is projected to grow by USD 4.18 Billion from 2024-2028, with AI driving transformation and rising demand for regional and ethnic flavors boosting growth - Technavio
Nutrition is a crucial factor, with some products fortified to address nutrient deficiencies and combat malnutrition. Amidst the COVID-19 pandemic, instant foods, including instant noodles, have seen a surge in demand as essential food items for home-cooked meals. Consumption has increased
More news about: Technavio
Sep 24, 2024, 14:34 ET New cancer diagnoses did not rebound as expected following pandemic
What: Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by researchers at the National Institutes of Health (NIH). However, there was little evidence of a rebound in incidence
More news about: NATIONAL CANCER INSTITUTE
Sep 24, 2024, 14:30 ET InventHelp Inventor Develops New Deodorant, Disinfectant & Air Freshener (HOF-557)
24, 2024 /PRNewswire/ -- "I wanted to create a new deodorant, disinfectant, and air freshener to help keep my family safe during the COVID-19 pandemic," said an inventor, from Houston, Texas, "so I invented the COVI- RID DISINFECTANT/ DEODORANT. My design
More news about: InventHelp